产品
编 号:F064226
分子式:C14H14FNO3
分子量:263.26
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
336
In-stock
5mg
800
In-stock
10mg
1280
In-stock
25mg
2176
In-stock
50mg
3360
In-stock
100mg
5040
In-stock
结构图
联系客服
产品详情
生物活性:
ASP7663 is an orally active and selective TRPA1 agonist. ASP7663 exerts both anti-constipation and anti-abdominal pain actions.

体内研究:
ASP7663 significantly improves the loperamide-induced delay in colonic transit in mice. ASP7663 (orally, 0.3 and 1 mg/kg) significantly shortens the prolonged bead expulsion time caused by loperamide.ASP7663 (orally, 1 and 3 mg/kg) exhibits inhibitory effects on colorectal distension in rat.Animal Model:CRD model (colorectal distension in rat).
Dosage:1 and 3 mg/kg.
Administration:Orally.
Result:Significantly reduced the number of abdominal contractions evoked during CRD at pressures of 30, 45, and 60 mmHg. ASP7663 also reduced the number of abdominal contractions by intravenous treatment.

体外研究:
ASP7663 concentration dependently increases intracellular Ca2+ concentration in human, rat, and mouse TRPA1 expressed in HEK293 cells in a similar manner, with respective EC50 values (95% confidence interval [CI]) of 0.51 (0.40–0.66), 0.54 (0.41–0.72), and 0.50 (0.41–0.63) μmol/L.ASP7663 concentration-dependently stimulates 5-HT release from QGP-1 cells, a lineage of TRPA1-expressing EC cells, with an EC50 value of 72.5 (52.6–99.9) μmol/L.
产品资料